Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
Photo: Ars TechnicaThe interim Phase I trial data was only from 35 people, but results look good so far
Why this matters for military families
Developments that affect daily life for service members and their families at duty stations worldwide.
Originally published by Ars Technica. Summary and curation by DutyStation.ai.
